Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05741333 · ClinicalTrials.gov registry record · NA
In-Office Clinical Study of the Solo+ TTD
A NA study of Otitis Media and Ear Infection, sponsored by AventaMed DAC.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 7
- Study locations
NCT05741333 is a NA study of Otitis Media and Ear Infection that is actively recruiting participants, run by AventaMed DAC. The registered enrollment target is 66 participants, below the 4,339-participant average among 14 other Otitis Media trials with a reported enrollment target (98% lower). The trial reports 7 study locations across 5 states.
The verdict
NCT05741333, a NA study of Otitis Media and Ear Infection, is actively recruiting participants, sponsored by AventaMed DAC.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 7
- Study locations
Study Summary
The objective of this study is to evaluate the safety and effectiveness of the Solo+ Tympanostomy Tube Device (Solo+ TTD) for the placement of tympanostomy tubes in paediatric patients undergoing a tympanostomy procedure.
Conditions Studied
Interventions
- DEVICE Solo+ Tympanostomy Tube Device (Solo+ TTD)
Study Locations (7)
Alabama
- Southern Head & Neck Surgery - Alexander City
- North Alabama ENT - Huntsville
- East Alabama ENT - Opelika
California
- Sacramento ENT - Sacramento
Kentucky
- Advanced ENT & Allergy - Louisville
Pennsylvania
- Specialty Physician Associates - Bethlehem
South Carolina
- South Carolina ENT - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2023-03-30 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05741333
The ClinicalTrials.gov registry entry for NCT05741333 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,339-participant average among 14 other Otitis Media trials with a reported enrollment target (98% lower). The listed sponsor is AventaMed DAC, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Otitis Media appearing as the primary indexed condition, and to 1 intervention - of which Solo+ Tympanostomy Tube Device (Solo+ TTD) is the first listed.
NCT05741333 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Alabama, California, Kentucky.
Frequently Asked Questions
What is clinical trial NCT05741333 about?
NCT05741333 is a clinical study titled "In-Office Clinical Study of the Solo+ TTD". The objective of this study is to evaluate the safety and effectiveness of the Solo+ Tympanostomy Tube Device (Solo+ TTD) for the placement of tympanostomy tubes in paediatric patients undergoing a tympanostomy procedure.
What is the current status of trial NCT05741333?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2023-03-30. Estimated completion is 2027-06.
What conditions does trial NCT05741333 study?
This clinical trial studies the following conditions: Otitis Media, Ear Infection.
What interventions are being tested in trial NCT05741333?
The interventions under investigation include: Solo+ Tympanostomy Tube Device (Solo+ TTD) (DEVICE).
Who is sponsoring clinical trial NCT05741333?
This trial is sponsored by AventaMed DAC, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05741333 being conducted?
This trial has 7 study locations across Alabama, California, Kentucky, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Otitis Media
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Coherent Optical Detection of Middle Ear Disease
RECRUITING · NA
-
Digital Otoscope Versus Education and Feedback for Otitis Media in Young Children
ACTIVE NOT RECRUITING · NA
-
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
COMPLETED · NA
-
In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old
COMPLETED · NA
-
Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11
COMPLETED · NA
-
Tympanostomy Tube Placement in Children in the Office (Inova Study)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.